PREVENTION OF SUDDEN CARDIAC DEATH AFTER MYOCARDIAL INFARCTION BY DEFIBRILLATOR IMPLANTATION
Prevention of sudden cardiac death: from analysis of existing data to a large-scale clinical trial
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.
Latest news
THE START OF THE PROFID EHRA CLINICAL TRIAL
With the initiation of the first clinical study sites in Bad Segeberg and Rothenburg, Germany, and the enrolment of the first patients, the PROFID EHRA trial has finally started. From now on the 30-month recruitment period is underway. The PROFID EHRA trial (NCT05665608) is set to answer the question if routine implantation of an implantable …
Project Information
Grant agreement ID: 847999
DOI: 10.3030/847999
Start date: 1st January 2020
End date: 31st December 2024
Funded under: SOCIETAL CHALLENGES – Health, demographic change and well-being
Overall budget: € 23,307,508.08
Coordinated by: Helios Health Institute GmbH